Powered by

MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman; - MedLumics' oversubscribed financing round closes at EUR 18M to advance optically-guided real-time ablation catheter technology for the treatment of Atrial Fibrillati

Feb 10, 2021 - PR Newswire
Board and Executive Moves-Investments

PR Newswire

MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board of Directors. MedLumics' optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conducti...